Distribution of tumor-infiltrating immune cells in glioblastoma

Author:

Orrego Enrique1,Castaneda Carlos A23,Castillo Miluska2,Bernabe Luis A2,Casavilca Sandro4,Chakravarti Arnab5,Meng Wei5,Garcia-Corrochano Pamela1,Villa-Robles Maria R4,Zevallos Rocio4,Mejia Omar2,Deza Pedro1,Belmar-Lopez Carolina2,Ojeda Luis1

Affiliation:

1. Neurosurgery Department, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038, Peru

2. Research Department, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038, Peru

3. Faculty of Medicine, Universidad Peruana San Juan Bautista, Lima, 15067, Peru

4. Pathology Department, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038, Peru

5. Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital, Columbus, OH, 43210, USA

Abstract

Aim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor-infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. Results: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4+ was associated with unmethylated MGMT (p = 0.016). Higher CD8+ was associated with larger tumoral size (p = 0.027). Higher CD163+ was associated with higher age (p = 0.044) and recursive partitioning analysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4+ (p < 0.05) were associated with longer overall survival. Conclusion: Macrophages are more frequent than TILs. Some subsets are associated with clinical features.

Publisher

Future Medicine Ltd

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3